Iambic Reports Q3 2026 Results, $252 Million in Cash and Pipeline Progress
Iambic reported third-quarter 2026 collaboration revenue of $11.4 million, up from $4.7 million a year earlier, and a net loss of $38.5 million. Cash and cash equivalents totaled $252 million at September 30, with pro forma cash of approximately $455 million after October IPO proceeds and AbbVie up…